Exploring the inhibitory activity and mechanism of cetylpyridine chloride: Unveiling a promising class of tyrosinase inhibitors

被引:1
|
作者
Chen, Jianmin [1 ,2 ]
Zhu, Danhong [1 ]
Feng, Baozhu [1 ]
Cai, Xiaozhen [1 ]
Chen, Juan [1 ]
机构
[1] Putian Univ, Sch Pharm & Med Technol, Putian, Fujian, Peoples R China
[2] Fujian Prov Univ, Putian Univ, Key Lab Pharmaceut Anal & Lab Med, Fuzhou, Fujian, Peoples R China
基金
中国国家自然科学基金;
关键词
Cetylpyridine chloride; Tyrosinase inhibitor; Inhibitory mechanism; Structure-activity relationship; Molecular docking; HUMAN SERUM-ALBUMIN; MUSHROOM TYROSINASE; DERIVATIVES; INSIGHTS; BINDING; DOCKING; STATES; SITE;
D O I
10.1016/j.procbio.2023.12.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cetylpyridine chloride (CPC), a quaternary ammonium compound renowned for its antimicrobial properties, has emerged as a promising tyrosinase inhibitor. However, the precise mechanism of its inhibitory effects remains elusive. Therefore, this study endeavors to elucidate CPC's inhibitory effects and molecular mechanisms through spectroscopic analyses and computational molecular docking. Our findings unveil CPC as a reversible, competitive inhibitor of tyrosinase, achieved through hydrophobic interactions that effectively obstruct the enzymatic active site. These insights prompted the evaluation of 25 CPC analogs, assessing their monophenolase and diphenolase activities. Notably, this investigation unveiled a previously unreported class of tyrosinase in-hibitors, making a substantial contribution to the existing literature. Furthermore, a preliminary structure-activity relationship analysis was conducted on a series of CPC analogs, indicating the necessity of a long alkyl chain with a minimum length of 14 carbons and a hydrophilic functional group. Our results demonstrate the potential for designing novel tyrosinase inhibitors with enhanced inhibitory capabilities, while also shedding light on surfactant-protein binding mechanisms.
引用
收藏
页码:282 / 291
页数:10
相关论文
共 50 条
  • [41] 2-(4-Fluorophenyl)-quinazolin-4(3H)-one as a novel tyrosinase inhibitor: Synthesis, inhibitory activity, and mechanism
    Wang, Rui
    Chai, Wei-Ming
    Yang, Qin
    Wei, Man-Kun
    Peng, Yiyuan
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (19) : 4620 - 4625
  • [42] The Relationship between the IC50 Values and the Apparent Inhibition Constant in the Study of Inhibitors of Tyrosinase Diphenolase Activity Helps Confirm the Mechanism of Inhibition
    Garcia-Molina, Pablo
    Garcia-Molina, Francisco
    Antonio Teruel-Puche, Jose
    Neptuno Rodriguez-Lopez, Jose
    Garcia-Canovas, Francisco
    Luis Munoz-Munoz, Jose
    [J]. MOLECULES, 2022, 27 (10):
  • [43] Development of a new class of aromatase inhibitors: Design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives
    Bonfield, Kevin
    Amato, Erica
    Bankemper, Tony
    Agard, Hannah
    Steller, Jeffrey
    Keeler, James M.
    Roy, David
    McCallum, Adam
    Paula, Stefan
    Ma, Lili
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (08) : 2603 - 2613
  • [44] INHIBITORY ACTIVITY AND MECHANISM OF INHIBITION OF THE N-[[(4-BENZOYLAMINO)PHENYL]SULFONYL]AMINO ACID ALDOSE REDUCTASE INHIBITORS
    DERUITER, J
    MAYFIELD, CA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 40 (10) : 2219 - 2226
  • [45] N- and s-substituted Pyrazolopyrimidines: A promising new class of potent c-Src kinase inhibitors with prominent antitumor activity
    Awaji, Aeshah A.
    El Zaloa, Waheed Ali Zaki
    Seleem, Mohamed A.
    Alswah, Mohamed
    Elsebaei, Mohamed M.
    Bayoumi, Ashraf H.
    El-Morsy, Ahmed M.
    Alfaifi, Mohammad Y.
    Shati, Ali A.
    Elbehairi, Serag Eldin I.
    Almaghrabi, Mohammed
    Aljohani, Ahmed K. B.
    Ahmed, Hany E. A.
    [J]. BIOORGANIC CHEMISTRY, 2024, 145
  • [46] Exploring QSARs for Inhibitory Activity of Non-peptide HIV-1 Protease Inhibitors by GA-PLS and GA-SVM
    Deeb, Omar
    Goodarzi, Mohammad
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2010, 75 (05) : 506 - 514
  • [47] Synthetic inhibitors of cytochrome P-450 2A6: Inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization
    Yano, Jason K.
    Denton, Travis T.
    Cerny, Matthew A.
    Zhang, Xiaodong
    Johnson, Eric F.
    Cashman, John R.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (24) : 6987 - 7001
  • [48] Novel cytomegalovirus-inhibitory compounds of the class pyrrolopyridines show a complex pattern of target binding that suggests an unusual mechanism of antiviral activity
    Hahn, Friedrich
    Hutterer, Corina
    Henry, Christophe
    Hamilton, Stuart T.
    Strojan, Hanife
    Kraut, Alexandra
    Schulte, Ulrike
    Schuetz, Martin
    Kohrt, Stephan
    Wangen, Christina
    Pfizer, Jose
    Coute, Yohann
    Rawlinson, William D.
    Strobl, Stefan
    Marschall, Manfred
    [J]. ANTIVIRAL RESEARCH, 2018, 159 : 84 - 94
  • [49] A pair of homoisoflavonoid analogues (6-aldehydo-isoophiopogonanone A/6-aldehydo-isoophiopogonanone B) from Ophiopogon japonicus as a tyrosinase inhibitor: inhibitory activity, conformational change and mechanism
    Wang, Liling
    Qin, Yuchuan
    Wang, Yanbin
    Liu, Bentong
    Zhou, Yifeng
    [J]. EUROPEAN FOOD RESEARCH AND TECHNOLOGY, 2022, 248 (02) : 553 - 565
  • [50] A pair of homoisoflavonoid analogues (6-aldehydo-isoophiopogonanone A/6-aldehydo-isoophiopogonanone B) from Ophiopogon japonicus as a tyrosinase inhibitor: inhibitory activity, conformational change and mechanism
    Liling Wang
    Yuchuan Qin
    Yanbin Wang
    Bentong Liu
    Yifeng Zhou
    [J]. European Food Research and Technology, 2022, 248 : 553 - 565